Morocco Stockpiles Chloroquine Drug for Potential COVID-19 Treatment
In the eyes of the Moroccan authorities, chloroquine could be a cure for the coronavirus. The Ministry of Health has purchased stocks of nivaquine, an antimalarial drug based on chloroquine, produced by the French group, Sanofi, in its Casablanca factories.
According to RFI, Sanofi Maroc has confirmed this purchase operation, which is accompanied by an additional order. But these stocks of nivaquine will be exported to sub-Saharan Africa where the coronavirus pandemic tends to rage.
On Wednesday, the Head of Government, Saâdeddine El Otmani, wrote on his Twitter account that Plaquenil can be used to treat all COVID-19 patients. Since tests have been carried out in France, there is a rush on Plaquenil stocks in pharmacies, a media outlet reports.
Related Articles
-
220 dirhams on construction sites, up to 400 in the fields: Morocco lacks workers
25 August 2026
-
This Israeli company equips defense giants and also has clients in Morocco
24 August 2026
-
After three days in Algeria, a sanctioned Russian ship passes near Morocco
24 August 2026
-
In Brussels, a Moroccan name and being over 50: the profile most disadvantaged in hiring
24 August 2026
-
Morocco Has a New Billionaire Forbes Has Yet to Spot
24 August 2026